Herbalife (NYSE: HLF) insider transactions
In the twelve months to 10 November 2026, executives and directors of Herbalife reported 4 open-market sales of 191,296 shares ($2.6m) and 4 open-market purchases of 19,400 shares ($181,510), by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 4 August 2026 | Lamberti Frank | Chief Commercial Officer | Shares withheld for tax | −1,710 | $12.80 | 34,914 | Form 4 |
| 4 June 2026 | L'Helias Sophie | Director | Open-market purchase | +1,200 | $11.31 | 79,882 | Form 4 |
| 19 May 2026 | Hicks Troy | Chief Operating Officer | Open-market sale | −10,000 | $12.32 | 9,706 | Form 4 |
| 18 May 2026 | Hicks Troy | Chief Operating Officer | Open-market sale | −38,377 | $12.93 | 9,062 | Form 4 |
| 18 May 2026 | Hicks Troy | Chief Operating Officer | Option exercise | +17,481 | $8.31 | 26,543 | Form 4 |
| 18 May 2026 | Hicks Troy | Chief Operating Officer | Shares withheld for tax | −14,562 | $12.59 | 11,981 | Form 4 |
| 18 May 2026 | Hicks Troy | Chief Operating Officer | Option exercise | +65,789 | $9.58 | 77,770 | Form 4 |
| 18 May 2026 | Hicks Troy | Chief Operating Officer | Shares withheld for tax | −58,064 | $12.59 | 19,706 | Form 4 |
| 12 May 2026 | Lamberti Frank | Chief Commercial Officer | Open-market sale | −134,982 | $13.50 | 36,624 | Form 4 |
| 11 May 2026 | Lamberti Frank | Chief Commercial Officer | Open-market sale | −7,937 | $13.86 | 171,606 | Form 4 |
| 8 May 2026 | Miller Perkins | Director | Grant or award | +13,626 | — | 50,769 | Form 4 |
| 8 May 2026 | L'Helias Sophie | Director | Grant or award | +11,879 | — | 78,682 | Form 4 |
| 8 May 2026 | Mulligan Donal L | Director | Grant or award | +11,879 | — | 68,982 | Form 4 |
| 8 May 2026 | Macadrai Rodica | Director | Grant or award | +11,879 | — | 67,441 | Form 4 |
| 8 May 2026 | Walsh Des | Director | Grant or award | +11,879 | — | 61,879 | Form 4 |
| 8 May 2026 | Mendoza Juan Miguel | Director | Grant or award | +11,879 | — | 181,879 | Form 4 |
| 8 May 2026 | Levitt Michael J | Director | Grant or award | +11,879 | — | 49,393 | Form 4 |
| 8 May 2026 | Carmona Richard H | Director | Grant or award | +11,879 | — | 83,645 | Form 4 |
| 8 May 2026 | Otero Maria | Director | Grant or award | +11,879 | — | 95,129 | Form 4 |
| 8 May 2026 | Cloud Lynda | Director | Grant or award | +11,879 | — | 50,736 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Herbalife page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.